Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by RedHill Biopharma Ltd
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
April 11, 2022
From
RedHill Biopharma Ltd
Via
AccessWire
Tickers
RDHL
RedHill Announces Additional Insider Buying
December 15, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Tickers
RDHL
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
December 09, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations
December 06, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI
December 02, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill’s Movantik Added To Medicare Formulary
December 01, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Reports 3Q/2021 Financial Results
November 30, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study
November 15, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill
November 08, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021
October 25, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Announces Insider Buying
October 18, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori
October 12, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL
October 06, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
October 04, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RHB-107 P2/3 COVID-19 Study South Africa Approval
September 13, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis
September 07, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek
September 07, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill to Present at HCW & Cantor Conferences
September 02, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Reports Second Quarter 2021 Results
August 26, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Supply Chain
Tickers
RDHL
RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition
August 26, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Announces Two New U.S. Patents
August 23, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Settles Movantik(R) Apotex Patent Litigation
July 22, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
RedHill Extends Talicia Commercial Coverage
July 20, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
RedHill Biopharma Ltd Announces RedHill Biopharma Announces Last Patient Out
July 19, 2021
From
RedHill Biopharma Ltd
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Tickers
RDHL
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
